Litcius/Paper detail

Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker

Yulia Liubomirski, Galia Tiram, Anna Scomparin, Samer Gnaim, Sayantan Das, Sachin P. Gholap, Liang Ge, Eilam Yeini, Omri Shelef, Arie Zauberman, Nir Berger, Doron Kalimi, Mira Toister‐Achituv, Christian Schröter, Stephan Dickgießer, Jason Tonillo, Min Shan, Carl Deutsch, Stanley Sweeney-Lasch, Doron Shabat, Ronit Satchi‐Fainaro

2024Journal of Controlled Release16 citationsDOI

Topics & Concepts

LinkerIn vivoChemistryConjugateAntibody-drug conjugateTrastuzumabProdrugCancer researchPharmacologyAntibodyCancerMonoclonal antibodyBiochemistryImmunologyMedicineBiologyInternal medicineBreast cancerMathematical analysisComputer scienceMathematicsOperating systemBiotechnologyHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research
Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker | Litcius